GlucoModicum is a company transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology. Its proprietary magnetohydrodynamics platform has the potential to radically change how people monitor their health, creating solutions that are precise, accessible and needle-free, empowering people to live healthier lives. The company’s first product is a non-invasive, wearable glucose monitor for patients suffering from diabetes. GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and combines an experienced, multi-disciplinary in-house team with world-class partners to deliver groundbreaking solutions for personal biomarker monitoring. For more information, please visit: www.glucomodicum.com